Barclays PLC Abiomed Inc Transaction History

Barclays PLC

  • $377 Billion
  • Q3 2024

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 03, 2022
BUY
$242.49 - $301.46 $3.02 Million - $3.76 Million
12,461 Added 33.0%
50,218 $12.3 Million
Q2 2022

Aug 12, 2022
SELL
$224.73 - $338.64 $4.18 Million - $6.3 Million
-18,618 Reduced 33.03%
37,757 $9.35 Million
Q1 2022

May 16, 2022
SELL
$277.25 - $366.29 $5.45 Million - $7.2 Million
-19,663 Reduced 25.86%
56,375 $18.7 Million
Q4 2021

Feb 14, 2022
SELL
$300.63 - $371.35 $1.76 Million - $2.17 Million
-5,839 Reduced 7.13%
76,038 $27.3 Million
Q3 2021

Nov 09, 2021
BUY
$310.19 - $376.2 $6.11 Million - $7.42 Million
19,713 Added 31.71%
81,877 $26.7 Million
Q2 2021

Aug 13, 2021
BUY
$262.71 - $351.17 $2.5 Million - $3.34 Million
9,524 Added 18.09%
62,164 $19.4 Million
Q1 2021

May 13, 2021
BUY
$285.92 - $355.13 $3.28 Million - $4.07 Million
11,466 Added 27.85%
52,640 $16.8 Million
Q4 2020

Feb 11, 2021
BUY
$251.88 - $324.2 $441,041 - $567,674
1,751 Added 4.44%
41,174 $13.3 Million
Q3 2020

Nov 12, 2020
BUY
$255.22 - $317.0 $3.28 Million - $4.07 Million
12,849 Added 48.35%
39,423 $10.9 Million
Q2 2020

Aug 12, 2020
SELL
$141.4 - $257.09 $3.88 Million - $7.06 Million
-27,450 Reduced 50.81%
26,574 $6.42 Million
Q1 2020

May 13, 2020
SELL
$130.51 - $196.01 $486,541 - $730,725
-3,728 Reduced 6.46%
54,024 $7.84 Million
Q4 2019

Feb 10, 2020
SELL
$159.31 - $223.54 $3.4 Million - $4.77 Million
-21,339 Reduced 26.98%
57,752 $9.85 Million
Q3 2019

Nov 14, 2019
BUY
$175.89 - $279.23 $552,646 - $877,340
3,142 Added 4.14%
79,091 $14.1 Million
Q2 2019

Aug 14, 2019
BUY
$250.96 - $284.94 $619,369 - $703,231
2,468 Added 3.36%
75,949 $19.8 Million
Q1 2019

May 15, 2019
BUY
$276.39 - $362.25 $8.34 Million - $10.9 Million
30,176 Added 69.68%
73,481 $21 Million
Q4 2018

Feb 14, 2019
SELL
$281.08 - $444.25 $6.08 Million - $9.6 Million
-21,618 Reduced 33.3%
43,305 $14.1 Million
Q3 2018

Nov 14, 2018
SELL
$354.53 - $449.75 $215,554 - $273,448
-608 Reduced 0.93%
64,923 $29.2 Million
Q2 2018

Aug 14, 2018
BUY
$278.07 - $446.21 $10.2 Million - $16.3 Million
36,548 Added 126.1%
65,531 $26.8 Million
Q1 2018

May 15, 2018
BUY
$192.49 - $295.85 $1.43 Million - $2.2 Million
7,450 Added 34.6%
28,983 $8.44 Million
Q4 2017

Feb 14, 2018
BUY
$168.78 - $199.74 $72,575 - $85,888
430 Added 2.04%
21,533 $4.04 Million
Q3 2017

Nov 14, 2017
BUY
$145.39 - $168.6 $3.07 Million - $3.56 Million
21,103
21,103 $3.56 Million

Others Institutions Holding ABMD

# of Institutions
12
Shares Held
137K
Call Options Held
0
Put Options Held
0
View Full List

About ABIOMED INC

ABMD Quotes by TradingView
  • Ticker ABMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 45,460,900
  • Description
  • Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...
More about ABMD
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email